• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Technology·AGYS
Share

Agilysys, Inc. Stocks

$ 91.15Last Updated 10.06.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

$ 2.54B

$ 91.15
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

20.05.2026 18:20

AI helped small-cap company Agilysys boost revenue. Shares soared

19.05.2026 15:52

Morning in New York: waiting for de-escalation of the conflict with Iran

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Agilysys, Inc., operating alongside its subsidiaries, specializes in creating and distributing a comprehensive range of technology solutions, including both hardware and software products, as well as associated services. The company primarily caters to the global hospitality sector, with its presence extending across North America, Europe, the Asia-Pacific region, and India. Its core offerings encompass critical systems such as point-of-sale (POS), property management (PMS), inventory and procurement, payment processing, reservations, and seating management, all designed to significantly elevate the guest experience. In addition to its product suite, Agilysys provides extensive technical support, ongoing maintenance, subscription-based services, and professional consulting. The company's advanced solutions serve a broad spectrum of clients within and related to hospitality, including gaming establishments, hotels, resorts, cruise lines, corporate foodservice providers, restaurants, universities, stadiums, and healthcare facilities. Founded in 1932, the enterprise originally operated as Pioneer-Standard Electronics, Inc. before officially adopting the name Agilysys, Inc. in 2003. The firm is headquartered in Alpharetta, Georgia.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of AGYS is 132 and suggests 46% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

11.06.2026 18:17

Trump has vowed to launch more strikes against Iran. Iran threatened to attack Musk's companies

11.06.2026 17:45

Italy's SJI promoted "Superjets" abroad. How does it survive under sanctions?

11.06.2026 17:26

ECB raises rate for first time since 2023

11.06.2026 17:00

IPO hopes and dreams: why iconic shortstop Jim Chanos doesn't believe SpaceX's valuation

11.06.2026 16:35

FDA decisions and clinical data: the main drivers in small-cap biotech through the end of June

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026